David Roth

Track

Insider profile

Currently holds a position at Syros Pharmaceuticals Inc

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Medical Officer Syros Pharmaceuticals Inc Dec. 1, 2015 -
Chief Medical Officer Infinity Pharmaceuticals Inc Feb. 4, 2014 - Sept. 11, 2015
Senior Vice President - Clinical Development and Medical Affairs Infinity Pharmaceuticals Inc Sept. 4, 2013 - Feb. 4, 2014
David Roth's trades of Syros Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
318.43
Quantity 37,453
Value US$1,235,323
Transaction date
Proposed sale
Price
4.95
Quantity 10,451
Value US$51,732
Transaction date
Proposed sale
Price
4.98
Quantity 150
Value US$747
Transaction date
Proposed sale
Price
4.95
Quantity 6,287
Value US$31,121
Transaction date
Proposed sale
Price
3.95
Quantity 6,287
Value US$24,834
Transaction date
Proposed sale
Price
3.95
Quantity 7,348
Value US$29,025
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-20 2024-11-18
S Sale
16,432 +14.7%
400.05
US$1,573,323 		16,432 +14.7% 400.05 US$1,573,323
2024-11-18 2024-11-18
PrS Proposed sale
37,453
318.43
US$1,235,323 		37,453 318.43 US$1,235,323
2024-04-05 2024-04-03
PlS Planned sale
7,276 +47.3%
293.85
US$4,941,406 		7,276 +47.3% 293.85 US$4,941,406
2024-04-03 2024-04-03
PrS Proposed sale
10,451
4.95
US$51,732 		10,451 4.95 US$51,732
2024-04-02 2024-04-02
PrS Proposed sale
150
4.98
US$747 		150 4.98 US$747
2024-04-02 2024-04-02
PlS Planned sale
150 -1.4%
4.98
US$747 		150 -1.4% 4.98 US$747
2023-12-14 2023-12-12
PlS Planned sale
6,287 -100.0%
4.95
US$31,121 		6,287 -100.0% 4.95 US$31,121
2023-12-12 2023-12-12
PrS Proposed sale
6,287
4.95
US$31,121 		6,287 4.95 US$31,121
2023-12-08 2023-12-06
PlS Planned sale
6,287 -50.0%
3.95
US$24,834 		6,287 -50.0% 3.95 US$24,834
2023-12-06 2023-12-06
PrS Proposed sale
6,287
3.95
US$24,834 		6,287 3.95 US$24,834
2023-08-02 2023-07-31
PlS Planned sale
7,348 -100.0%
3.95
US$29,025 		7,348 -100.0% 3.95 US$29,025
2023-07-31 2023-07-31
PrS Proposed sale
7,348
3.95
US$29,025 		7,348 3.95 US$29,025